Bringing you the latest cutting-edge research and commentary in bioscience.

Cell & Gene Therapy Insights

Cell & Gene Therapy Insights

Spotlight Article

Scaling AAV vector manufacture: overcoming roadblocks to the translation of gene therapies

Viral vector bioprocessing & analytics: today’s key tools and innovation requirements to meet future demand

Nicole Faust


Nicole Faust, CEO, CEVEC Pharmaceuticals

“The major challenge I anticipate will be to bring down production costs. The current price of gene therapies makes it inaccessible to so many patients worldwide.”

DOI: 10.18609/cgti.2020.074
Citation: Cell & Gene Therapy Insights 2020; 6(3), 617–623
Open access
This content is restricted to registered users. Click here to Register or Login here.
Twitter IconVisit Our Blog